JAK inhibitors and other oral immunology drugs on Wellcare Value Script (S4802-147)
Rinvoq, Xeljanz, Olumiant and Otezla, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Alabama + 1 more
- Premium
- $3.60/month
- Deductible
- $615.00, doesn't apply to tier 1 and 2
2 of 5 JAK inhibitors are covered on this plan. All 2 require prior authorization.
3 aren't on the formulary, including Xeljanz and Olumiant.
- from $1,556.00Tier 5
- from $216.81Tier 5
Not on the formulary
Xeljanz, Olumiant, Sotyktu
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.